AFP and neoplasm: Thus, Song and coworkers have explored the correlation between CD133 expression and clinico-pathological data and observed that: (a) increased CD133 expression levels correlate with tumor grade, stage disease and alpha-fetoprotein levels; (b) patients with increased CD133 levels had shorter overall survival and higher recurrence rates [128].